Cargando…
Fluorescent reporter assays provide direct, accurate, quantitative measurements of MGMT status in human cells
The DNA repair protein O(6)-methylguanine DNA methyltransferase (MGMT) strongly influences the effectiveness of cancer treatment with chemotherapeutic alkylating agents, and MGMT status in cancer cells could potentially contribute to tailored therapies for individual patients. However, the promoter...
Autores principales: | Nagel, Zachary D., Beharry, Andrew A., Mazzucato, Patrizia, Kitange, Gaspar J., Sarkaria, Jann N., Kool, Eric T., Samson, Leona D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392231/ https://www.ncbi.nlm.nih.gov/pubmed/30811507 http://dx.doi.org/10.1371/journal.pone.0208341 |
Ejemplares similares
-
Fluorogenic Real-Time Reporters of DNA Repair by MGMT, a Clinical Predictor of Antitumor Drug Response
por: Beharry, Andrew A., et al.
Publicado: (2016) -
TRANSLATIONAL RESEARCH-03 MULTIPLE MECHANISMS MODULATE TEMOZOLOMIDE RESISTANCE AND ARE POTENTIAL TARGETS FOR GLIOBLASTOMA THERAPY.
por: Kitange, Gaspar, et al.
Publicado: (2023) -
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
por: Chen, Xiaoyue, et al.
Publicado: (2018) -
Alkylation induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins
por: Bugni, James M., et al.
Publicado: (2008) -
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
por: Rosas-Alonso, Rocio, et al.
Publicado: (2021)